[Does radiation therapy for prostate cancer increase the risk of second cancers?]
- PMID: 38876938
- DOI: 10.1016/j.canrad.2023.07.018
[Does radiation therapy for prostate cancer increase the risk of second cancers?]
Abstract
Purpose: The increased risk of second cancer after prostate radiotherapy is a debated clinical concern. The objective of the study was to assess the risk of occurrence of second cancers after prostate radiation therapy based on the analysis the literature, and to identify potential factors explaining the discrepancies in results between studies.
Materials and methods: A review of the literature was carried out, comparing the occurrence of second cancers in patients all presenting with prostate cancer, treated or not by radiation.
Results: This review included 30 studies reporting the occurrence of second cancers in 2,112,000 patients treated or monitored for localized prostate cancer, including 1,111,000 by external radiation therapy and 103,000 by brachytherapy. Regarding external radiation therapy, the average follow-up was 7.3years. The majority of studies (80%) involving external radiation therapy, compared to no external radiation therapy, showed an increased risk of second cancers with a hazard ratio ranging from 1.13 to 4.9, depending on the duration of the follow-up. The median time to the occurrence of these second cancers after external radiotherapy ranged from 4 to 6years. An increased risk of second rectal and bladder cancer was observed in 52% and 85% of the studies, respectively. Considering a censoring period of more than 10 years after irradiation, 57% and 100% of the studies found an increased risk of rectal and bladder cancer, without any impact in overall survival. Studies of brachytherapy did not show an increased risk of second cancer. However, these comparative studies, most often old and retrospective, had many methodological biases.
Conclusion: Despite numerous methodological biases, prostate external radiation therapy appears associated with a moderate increase in the risk of second pelvic cancer, in particular bladder cancer, without impacting survival. Brachytherapy does not increase the risk of a second cancer.
Keywords: Cancer; Prostate; Prostate cancer; Radio-induced; Radio-induit; Radiotherapy; Radiothérapie; Second cancer; Second primary cancer.
Copyright © 2024 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.Radiother Oncol. 2016 Aug;120(2):293-9. doi: 10.1016/j.radonc.2016.05.026. Epub 2016 Jun 29. Radiother Oncol. 2016. PMID: 27370205
-
Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):669-73. doi: 10.1016/j.ijrobp.2006.05.016. Epub 2006 Aug 2. Int J Radiat Oncol Biol Phys. 2006. PMID: 16887293
-
Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.BJU Int. 2012 Dec;110(11):1696-701. doi: 10.1111/j.1464-410X.2012.11385.x. Epub 2012 Aug 13. BJU Int. 2012. PMID: 22889401
-
Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.Ann ICRP. 2005;35(3):iii-vi, 3-50. doi: 10.1016/j.icrp.2005.07.001. Ann ICRP. 2005. PMID: 16330284 Review.
-
[Second neoplasms after percutaneous radiotherapy].Urologe A. 2017 Mar;56(3):342-350. doi: 10.1007/s00120-016-0277-0. Urologe A. 2017. PMID: 27844130 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical